214 related articles for article (PubMed ID: 9308887)
21. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
[TBL] [Abstract][Full Text] [Related]
22. Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.
Yoon JH; Kim JK; Rha GB; Oh M; Park SH; Seong RH; Hong SH; Park SD
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):367-74. PubMed ID: 10567217
[TBL] [Abstract][Full Text] [Related]
23. The N-terminal domain of human topoisomerase IIalpha is a DNA-dependent ATPase.
Gardiner LP; Roper DI; Hammonds TR; Maxwell A
Biochemistry; 1998 Dec; 37(48):16997-7004. PubMed ID: 9836594
[TBL] [Abstract][Full Text] [Related]
24. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL
Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769
[TBL] [Abstract][Full Text] [Related]
25. Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha.
Herzog CE; Holmes KA; Tuschong LM; Ganapathi R; Zwelling LA
Cancer Res; 1998 Dec; 58(23):5298-300. PubMed ID: 9850052
[TBL] [Abstract][Full Text] [Related]
26. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
[TBL] [Abstract][Full Text] [Related]
28. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.
Errington F; Willmore E; Leontiou C; Tilby MJ; Austin CA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921
[TBL] [Abstract][Full Text] [Related]
29. Identification of a single nuclear localization signal in the C-terminal domain of an Aspergillus DNA topoisomerase II.
Kim KH; Kanbe T; Akashi T; Mizuguchi I; Kikuchi A
Mol Genet Genomics; 2002 Nov; 268(3):287-97. PubMed ID: 12436251
[TBL] [Abstract][Full Text] [Related]
30. Substrate specificity plays an important role in uncoupling the catalytic and scaffolding activities of rat testis DNA topoisomerase IIalpha.
Bakshi R; Galande S; Muniyappa K
J Biomol Struct Dyn; 2001 Apr; 18(5):749-60. PubMed ID: 11334111
[TBL] [Abstract][Full Text] [Related]
31. Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.
Kroll DJ; Sullivan DM; Gutierrez-Hartmann A; Hoeffler JP
Mol Endocrinol; 1993 Mar; 7(3):305-18. PubMed ID: 8387155
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells.
Christensen MO; Larsen MK; Barthelmes HU; Hock R; Andersen CL; Kjeldsen E; Knudsen BR; Westergaard O; Boege F; Mielke C
J Cell Biol; 2002 Apr; 157(1):31-44. PubMed ID: 11927602
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
Satterwhite DJ; White RL; Matsunami N; Neufeld KL
Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
[TBL] [Abstract][Full Text] [Related]
34. Functional interaction between human topoisomerase IIalpha and retinoblastoma protein.
Bhat UG; Raychaudhuri P; Beck WT
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7859-64. PubMed ID: 10393912
[TBL] [Abstract][Full Text] [Related]
35. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
Staley BE; Samowitz WS; Bronstein IB; Holden JA
Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
[TBL] [Abstract][Full Text] [Related]
36. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
Constantinou AI; Vaughan AT; Yamasaki H; Kamath N
Cancer Res; 1996 Sep; 56(18):4192-9. PubMed ID: 8797591
[TBL] [Abstract][Full Text] [Related]
37. Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA.
Bechert T; Diekmann S; Arndt-Jovin DJ
J Biomol Struct Dyn; 1994 Dec; 12(3):605-23. PubMed ID: 7727061
[TBL] [Abstract][Full Text] [Related]
38. The highly basic ribosomal protein L41 interacts with the beta subunit of protein kinase CKII and stimulates phosphorylation of DNA topoisomerase IIalpha by CKII.
Lee JH; Kim JM; Kim MS; Lee YT; Marshak DR; Bae YS
Biochem Biophys Res Commun; 1997 Sep; 238(2):462-7. PubMed ID: 9299532
[TBL] [Abstract][Full Text] [Related]
39. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.
Boege F; Andersen A; Jensen S; Zeidler R; Kreipe H
Am J Pathol; 1995 Jun; 146(6):1302-8. PubMed ID: 7539979
[TBL] [Abstract][Full Text] [Related]
40. Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively.
Tan KB; Dorman TE; Falls KM; Chung TD; Mirabelli CK; Crooke ST; Mao J
Cancer Res; 1992 Jan; 52(1):231-4. PubMed ID: 1309226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
